April 2020, Volume 6, Issue 5
This issue examines current immunization guidelines for patients with hematologic disorders, considers medical education amid the coronavirus pandemic, and more.
March 2020, Volume 6, Issue 4
This issue looks at how cost-effective analyses are used to inform health-care decisions, explains the latest maintenance of certification requirements, and more.
Focus on Lymphoid & Plasma Cell Malignancies (Volume 6, Issue 4.1)
This supplement takes a look at the future of chemoimmunotherapy for chronic lymphocytic leukemia, the latest FDA approvals for the treatment of lymphoid and plasma cell malignancies, and more.
February 2020, Volume 6, Issue 3
This issue examines the high price of treating hemophilia, asks whether CAR T-cell therapies are worth the cost, and more.
January 2020 Annual Meeting Edition
This issue features highlights from the 2019 ASH Annual Meeting, reflections on physician wellness, and more.
January 2020, Volume 6, Issue 1
This issue features a discussion about value-based care initiatives, coverage of late-breaking abstracts presented at the 2019 ASH Annual Meeting, and more.
December 2019, Volume 5, Issue 15
This issue examines the hidden costs of participating in clinical trials, explores the pediatric hematology/oncology workforce, and more.
November 2019 Bonus ASH Annual Meeting Preview Edition (Volume 5, Issue 14)
This issue offers an inside look at this year’s annual meeting, advice for giving effective presentations, and more.
November 2019, Volume 5, Issue 13
This issue features explores treating older patients with frailty, discusses the management of primary mediastinal B-cell lymphoma, and more.
Focus on Classical Hematology (Volume 5, Issue 12.1)
This supplement explores new treatment options for hemophilia, gene therapy in nonmalignant hematologic disorders, and more.
Current Issue
April 2020, Volume 6, Issue 5
This issue examines current immunization guidelines for patients with hematologic disorders, considers medical education amid the coronavirus pandemic, and more.
